Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Puma Biotechnology stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PBYI.
You can purchase shares of Puma Biotechnology (NASDAQ:PBYI) through any online brokerage.
Other companies in Puma Biotechnology’s space includes: Molecular Partners (NASDAQ:MOLN), Kalaris Therapeutics (NASDAQ:KLRS), Innate Pharma (NASDAQ:IPHA), 4D Molecular Therapeutics (NASDAQ:FDMT) and Quoin Pharmaceuticals (NASDAQ:QNRX).
Puma Biotechnology has a consensus price target of $7.00.
The stock price for Puma Biotechnology (NASDAQ: PBYI) is $2.86 last updated April 17, 2025 at 4:00 PM EDT.
There are no upcoming dividends for Puma Biotechnology.
Puma Biotechnology’s Q1 earnings are confirmed for Thursday, May 1, 2025.
There is no upcoming split for Puma Biotechnology.
Puma Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.